Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)

BACKGROUND: Cyclophosphamide-methotrexate-5-fluorouracil (CMF) is often selected as adjuvant chemotherapy for older patients with early-stage breast cancer due to perceived superior tolerability. We sought to measure persistence with CMF, adherence to oral cyclophosphamide, and the association of th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ruddy, K. J., Pitcher, B. N., Archer, L. E., Cohen, H. J., Winer, E. P., Hudis, C. A., Muss, H. B., Partridge, A. H.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2012
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3501229/
https://ncbi.nlm.nih.gov/pubmed/22767584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mds133
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados